Quantitation of intracellular triphosphate metabolites of antiretroviral agents in peripheral blood mononuclear cells (PBMCs) and corresponding cell count determinations: review of current methods and challenges

References

• Flexner C, Saag M. The antiretroviral drug pipeline: prospects and implications for future treatment research. Curr Opin HIV AIDS. 2013;8:572–578.
   PubMed Web of Science ®Google Scholar
• Ivetac A, McCammon JA. Elucidating the inhibition mechanism of HIV-1 non-nucleoside reverse transcriptase inhibitors through multicopy molecular dynamics simulations. J Mol Biol. 2009;388:644–658.
   PubMed Web of Science ®Google Scholar
• Tseng A, Seet J, Phillips EJ. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. Br J Clin Pharmacol. 2015;79:182–194.
   PubMed Web of Science ®Google Scholar
• Lai JP, Wang J, Cai ZW. Nucleoside reverse transcriptase inhibitors and their phosphorylated metabolites in human immunodeficiency virus-infected human matrices. J Chromatogr B – Anal Technol Biomed Life Sci. 2008;868:1–12.
   PubMed Web of Science ®Google Scholar
• Cihlar T. Nucleotide HIV reverse transcriptase inhibitors: tenofovir and beyond. Curr Opin HIV AIDS. 2006;1:373–379.
   PubMed Web of Science ®Google Scholar
• Derissen EJ, Hillebrand MJ, Rosing H, et al. Quantitative determination of azacitidine triphosphate in peripheral blood mononuclear cells using liquid chromatography coupled with high-resolution mass spectrometry. J Pharm Biomed Anal. 2014;90:7–14.
   PubMed Web of Science ®Google Scholar
• Huang LS, Lizak P, Aweeka F, et al. Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC–MS/MS. J Pharm Biomed Anal. 2013;86:198–203.
   PubMed Web of Science ®Google Scholar
• Ham AS, Buckheit RW Jr. Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors. Ther Deliv. 2015;6:217–229.
   PubMed Web of Science ®Google Scholar
• De Clercq E, Cutting-Edge A. View on the current state of antiviral drug development. Med Res Rev. 2013;33:1249–1277.
   PubMed Web of Science ®Google Scholar
• De Clercq E. The acyclic nucleoside phosphonates (ANPs): Antonin Holy’s Legacy. Med Res Rev. 2013;33:1278–1303.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/0. 2017; date last accessed 2018 Apr 2.
   Google Scholar
• Hawkins T, Veikley W, St Claire RL 3rd, et al. Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens. J Acquir Immune Defic Syndr. 2005;39:406–411.
   PubMed Web of Science ®Google Scholar
• Koeplinger KA, Raub TJ, Padbury GE, et al. Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium. J Pharm Biomed Anal. 1999;19:399–411.
   PubMed Web of Science ®Google Scholar
• Crommentuyn KM, Huitema AD, Beijnen JH. Bioanalysis of HIV protease inhibitors in samples from sanctuary sites. J Pharm Biomed Anal. 2005;38:139–147.
   PubMed Web of Science ®Google Scholar
• Durand-Gasselin L, da Silva D, Benech H, et al. Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells. Antimicrob Agents Chemother. 2007;51:2105–2111.
   PubMed Web of Science ®Google Scholar
• La J, Latham CF, Tinetti RN, et al. Identification of mechanistically distinct inhibitors of HIV-1 reverse transcriptase through fragment screening. Proc Natl Acad Sci U S A. 2015;112:6979–6984.
   PubMed Web of Science ®Google Scholar
• Lee WA, He GX, Eisenberg E, et al. Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue. Antimicrob Agents Chemother. 2005;49:1898–1906.
   PubMed Web of Science ®Google Scholar
• Ray AS. Intracellular interactions between nucleos(t)ide inhibitors of HIV reverse transcriptase. AIDS Rev. 2005;7:113–125.
   PubMed Web of Science ®Google Scholar
• Khoo SH, Hoggard PG, Williams I, et al. Intracellular accumulation of human immunodeficiency virus protease inhibitors. Antimicrob Agents Chemother. 2002;46:3228–3235.
   PubMed Web of Science ®Google Scholar
• di Lello FA, Culasso ACA, Parodi C, et al. New evidence of replication of hepatitis C virus in short-term peripheral blood mononuclear cell cultures. Virus Research. 2014;191:1–9.
   PubMed Web of Science ®Google Scholar
• Fletcher CV, Kawle SP, Kakuda TN, et al. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons. AIDS. 2000;14:2137–2144.
   PubMed Web of Science ®Google Scholar
• le Saint C, Terreux R, Duval D, et al. Determination of ddATP levels in human immunodeficiency virus-infected patients treated with dideoxyinosine. Antimicrob Agents Chemother. 2004;48:589–595.
   PubMed Web of Science ®Google Scholar
• Ruane PJ, DeJesus E, Berger D, et al. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults. J Acquir Immune Defic Syndr. 2013;63:449–455.
   PubMed Web of Science ®Google Scholar
• Bushman LR, Kiser JJ, Rower JE, et al. Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC–MS/MS detection. J Pharm Biomed Anal. 2011;56:390–401.
   PubMed Web of Science ®Google Scholar
• Cahours X, Tran TT, Mesplet N, et al. Analysis of intracellular didanosine triphosphate at sub-ppb level using LC–MS/MS. J Pharm Biomed Anal. 2001;26:819–827.
   PubMed Web of Science ®Google Scholar
• FDA-Approved HIV Medicines U.S. Department of Health and Human Services: https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/21/58/fda-approved-hiv-medicines. 2018; date last accessed 2018 Apr 2.
   Google Scholar
• Adams JL, Sykes C, Menezes P, et al. Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence? J Acquir Immune Defic Syndr. 2013;62:260–266.
   PubMed Web of Science ®Google Scholar
• Baheti G, Kiser JJ, Havens PL, et al. Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients. Antimicrob Agents Chemother. 2011;55:5294–5299.
   PubMed Web of Science ®Google Scholar
• Wang LZ, Soon GH, Seng KY, et al. Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteers. Antimicrob Agents Chemother. 2011;55:4090–4095.
   PubMed Web of Science ®Google Scholar
• Pruvost A, Negredo E, Benech H, et al. Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2005;49:1907–1914.
   PubMed Web of Science ®Google Scholar
• Pruvost A, Negredo E, Theodoro F, et al. Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir. Antimicrob Agents Chemother. 2009;53:1937–1943.
   PubMed Web of Science ®Google Scholar
• Robbins BL, Srinivas RV, Kim C, et al. Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), bis(isopropyloxymethylcarbonyl) PMPA. Antimicrob Agents Chemother. 1998;42:612–617.
   PubMed Web of Science ®Google Scholar
• Wang LH, Begley J, St Claire RL 3rd, et al. Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection. AIDS Res Hum Retroviruses. 2004;20:1173–1182.
   PubMed Web of Science ®Google Scholar
• Jackson A, Moyle G, Watson V, et al. Tenofovir, emtricitabine intracellular and plasma, and efavirenz plasma concentration decay following drug intake cessation: implications for HIV treatment and prevention. J Acquir Immune Defic Syndr. 2013;62:275–281.
   PubMed Web of Science ®Google Scholar
• Pruvost A, Negredo E, Theodoro F, et al. Pilot PK study of human immunodeficiency virus-infected patients receiving Tenofovir Disoproxil Fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir. Antimicrob Agents Ch. 2009;53:1937–1943.
   PubMed Web of Science ®Google Scholar
• Birkus G, Wang R, Liu XH, et al. Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131. Antimicrob Agents Chemother. 2007;51:543–550.
   PubMed Web of Science ®Google Scholar
• McDermott M, Birkus G, Wang R, et al. Cathepsin A is the major hydrolase catalyzing the intracelllular activation of nucleotide phosphoramidate prodrugs GS-7340 and GS-9131. Antiviral Research. 2006;70:A61–A62.
   Web of Science ®Google Scholar
• van Rompay KKA, Kearney BP, Sexton JJ, et al. Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus. J Acquir Immune Defic Syndr. 2006;43:6–14.
   PubMed Web of Science ®Google Scholar
• Anderson PL, Kiser JJ, Gardner EM, et al. Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother. 2011;66:240–250.
   PubMed Web of Science ®Google Scholar
• Furman PA, Fyfe JA, St Clair MH, et al. Phosphorylation of 3ʹ-azido-3ʹ-deoxythymidine and selective interaction of the 5ʹ-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A. 1986;83:8333–8337.
   PubMed Web of Science ®Google Scholar
• Dumond JB, Reddy YS, Troiani L, et al. Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men. J Acquir Immune Defic Syndr. 2008;48:156–162.
   PubMed Web of Science ®Google Scholar
• Lan X, Mingdao L, Huilin G, et al. Simultaneous determination of 2ʹ,3ʹ-dideoxyinosine and the active metabolite, 2ʹ,3ʹ-dideoxyadenosine-5ʹ-triphosphate in human peripheral-blood mononuclear cell by HPLC–MS/MS and the application to cell pharmacokinetics. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1002:337–342.
   PubMed Web of Science ®Google Scholar
• Huang L, Lizak P, Aweeka F, et al. Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC–MS/MS. J Pharm Biomed Anal. 2013;86:198–203.
   PubMed Web of Science ®Google Scholar
• Jemal M, Rao S, Gatz M, et al. Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for high-throughput analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;795:273–289.
   PubMed Web of Science ®Google Scholar
• Colombo S, Beguin A, Telenti A, et al. Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;819:259–276.
   PubMed Web of Science ®Google Scholar
• Else LJ, Jackson A, Puls R, et al. Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 study. Antimicrob Agents Chemother. 2012;56:1427–1433.
   PubMed Web of Science ®Google Scholar
• Ls T, Zack J, Yan M, et al. Enhanced exposure of Tenofovir-diphosphate (Tfv-Dp) in Peripheral blood mononuclear cells (Pbmc) by Tenofovir alafenamide (Taf) compared with Tenofovir disoproxil fumarate (Tdf). Boston, USA: ASM Microbe 2016; 2016.
   Google Scholar
• Moore JD, Valette G, Darque A, et al. Simultaneous quantitation of the 5ʹ-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry. J Am Soc Mass Spectrom. 2000;11:1134–1143.
   PubMed Web of Science ®Google Scholar
• Moore JD, Acosta EP, Johnson VA, et al. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy. Antivir Ther. 2007;12:981–986.
   PubMed Web of Science ®Google Scholar
• Borroto-Esoda K, Vela JE, Myrick F, et al. In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine. Antivir Ther. 2006;11:377–384.
   PubMed Web of Science ®Google Scholar
• Becher F, Pruvost A, Gale J, et al. A strategy for liquid chromatography/tandem mass spectrometric assays of intracellular drugs: application to the validation of the triphosphorylated anabolite of antiretrovirals in peripheral blood mononuclear cells. J Mass Spectrom. 2003;38:879–890.
   PubMed Web of Science ®Google Scholar
• Moyle G, Boffito M, Fletcher C, et al. Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother. 2009;53:1532–1538.
   PubMed Web of Science ®Google Scholar
• Shi G, Wu JT, Li Y, et al. Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2002;16:1092–1099.
   PubMed Web of Science ®Google Scholar
• Heyer NJ, Derzon JH, Winges L, et al. Effectiveness of practices to reduce blood sample hemolysis in EDs: a laboratory medicine best practices systematic review and meta-analysis. Clin Biochem. 2012;45:1012–1032.
   PubMed Web of Science ®Google Scholar
• Makroo RN, Raina V, Bhatia A, et al. Evaluation of the red cell hemolysis in packed red cells during processing and storage. Asian J Transfus Sci. 2011;5:15–17.
   PubMedGoogle Scholar
• Sawant RB, Jathar SK, Rajadhyaksha SB, et al. Red cell hemolysis during processing and storage. Asian J Transfus Sci. 2007;1:47–51.
   PubMedGoogle Scholar
• Jansen RS, Rosing H, Schellens JH, et al. Protein versus DNA as a marker for peripheral blood mononuclear cell counting. Anal Bioanal Chem. 2009;395:863–867.
   PubMed Web of Science ®Google Scholar
• Durand-Gasselin L, Da Silva D, Benech H, et al. Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells. Antimicrob Agents Chemother. 2007;51:2105–2111.
   PubMed Web of Science ®Google Scholar
• Darque A, Valette G, Rousseau F, et al. Quantitation of intracellular triphosphate of emtricitabine in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1999;43:2245–2250.
   PubMed Web of Science ®Google Scholar
• Gautam N, Lin Z, Banoub MG, et al. Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC–MS/MS. J Pharm Biomed Anal. 2018;153:248–259.
   PubMed Web of Science ®Google Scholar
• Benech H, Theodoro F, Herbet A, et al. Peripheral blood mononuclear cell counting using a DNA-detection-based method. Anal Biochem. 2004;330:172–174.
   PubMed Web of Science ®Google Scholar
• Robbins BL, Poston PA, Neal EF, et al. Simultaneous measurement of intracellular triphosphate metabolites of zidovudine, lamivudine and abacavir (carbovir) in human peripheral blood mononuclear cells by combined anion exchange solid phase extraction and LC–MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;850:310–317.
   PubMed Web of Science ®Google Scholar
• Barry M, Wild M, Veal G, et al. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers. AIDS. 1994;8:F1–5.
   PubMed Web of Science ®Google Scholar
• Eisenberg EJ, He GX, Lee WA. Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood. Nucleosides Nucleotides Nucl Acids. 2001;20:1091–1098.
   PubMed Web of Science ®Google Scholar
• McKeown AP, Shaw PN, Barrett DA. Electrophoretic behaviour of oligonucleotides and mono-, di- and triphosphate nucleotides by capillary zone electrophoresis. Electrophoresis. 2001;22:1119–1126.
   PubMed Web of Science ®Google Scholar
• Dolan JW. Ion pairing — blessing or curse? LC GC. 2008;21:258–263.
   Google Scholar
• Zhao Y, Liu GW, Liu YF, et al. Improved ruggedness of an ion-pairing liquid chromatography/tandem mass spectrometry assay for the quantitative analysis of the triphosphate metabolite of a nucleoside reverse transcriptase inhibitor in peripheral blood mononuclear cells. Rapid Communications Mass Spectrometry. 2013;27:481–488.
   PubMed Web of Science ®Google Scholar
• Claire RL 3rd Positive ion electrospray ionization tandem mass spectrometry coupled to ion-pairing high-performance liquid chromatography with a phosphate buffer for the quantitative analysis of intracellular nucleotides. Rapid Commun Mass Spectrom. 2000;14:1625–1634.
   PubMedGoogle Scholar
• Pruvost A, Becher F, Bardouille P, et al. Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2001;15:1401–1408.
   PubMed Web of Science ®Google Scholar
• Becher F, Pruvost A, Goujard C, et al. Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral-blood mononuclear cells using high-performance liquid chromatography/tandem mass spectrometry (vol 16, pg 555, 2002). Rapid Commun Mass Sp. 2007;21:2168.
   Google Scholar
• Pruvost A, Theodoro F, Agrofoglio L, et al. Specificity enhancement with LC-positive ESI-MS/MS for the measurement of nucleotides: application to the quantitative determination of carbovir triphosphate, lamivudine triphosphate and tenofovir diphosphate in human peripheral blood mononuclear cells. J Mass Spectrom. 2008;43:224–233.
   PubMed Web of Science ®Google Scholar
• James I, Watters SML, Loughran ED. The complexes of triphosphate ion with alkali metal ions. J Am Chem Soc. 1957;79:3651–3654.
   Web of Science ®Google Scholar
• Yan Z, Sun J, Wang J, et al. Simultaneous determination of didanosine and its amino acid prodrug, valdidanosine by hydrophilic interaction chromatography coupled with electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:466–470.
   PubMedGoogle Scholar
• Pruvost A, Theodoro F, Agrofoglio L, et al. Specificity enhancement with LC-positive ESI-MS/MS for the measurement of nucleotides: application to the quantitative determination of carbovir triphosphate, lamivudine triphosphate and tenofovir diphosphate in human peripheral blood mononuclear cells. J Spectrom. 2008;43:224–233.
   PubMed Web of Science ®Google Scholar
• Chen P, Liu ZF, Liu SJ, et al. A LC–MS/MS method for the analysis of intracellular nucleoside triphosphate levels. Pharm Res. 2009;26:1504–1515.
   PubMed Web of Science ®Google Scholar
• Kuklenyik Z, Martin A, Pau CP, et al. Effect of mobile phase pH and organic content on LC–MS analysis of nucleoside and nucleotide HIV reverse transcriptase inhibitors. J Chromatogr Sci. 2009;47:365–372.
   PubMed Web of Science ®Google Scholar
• Peng Y, Hou Y, Zhang F, et al. A hyperbranched polyethylenimine functionalized stationary phase for hydrophilic interaction liquid chromatography. Anal Bioanal Chem. 2016;408:3633–3638.
   PubMed Web of Science ®Google Scholar
• Xiao D, Ling J, Tarnowski T. The determination of antiretroviral triphosphate metabolite in human peripheral blood mononuclear cells. In: Lee M, ed. 9th Annual Shanghai Symposium on Clinical and Pharmaceutical Solutions through Analysis (CPSA Shanghai 2018) – New Horizons in Drug Discovery and Development: Bioanalysis, Biomarkers and ADME. Shanghai, China: 2018.
   Google Scholar
• FDA. Guidance for Industry: Bioanalytical method validation. Office of Communications, Division of Drug Information, Center for Drug Evaluation and Research, Food and Drug Administration, Sliver Spring, MD, US, 2013.
   Google Scholar
• Compain S, Durand-Gasselin L, Grassi J, et al. Improved method to quantify intracellular zidovudine mono- and triphosphate in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry. J Mass Spectrom. 2007;42:389–404.
   PubMed Web of Science ®Google Scholar
• Rs J, Rosing H, Kromdijk W, et al. Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci. 2010;878:621–627.
   PubMed Web of Science ®Google Scholar
• Handin RISELTPS. Blood: principles and practice of hematology. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2003.
   Google Scholar
• Daniels VG, Wheater PR, Burkitt HG. Functional histology: a text and colour atlas. Edinburgh: Churchill Livingstone; 1979.
   Google Scholar
• Cappione A, Crossley E, Thirumalapura N, et al. Immuno-monitoring using the scepter 2.0 cell counter and software module. Cell Solutions. 2011;2:18.
   Google Scholar
• Segel GB, Cokelet GR, Lichtman MA. The measurement of lymphocyte volume: importance of reference particle deformability and counting solution tonicity. Blood. 1981;57:894–899.
   PubMed Web of Science ®Google Scholar
• Gao WY, Cara A, Gallo RC, et al. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc Natl Acad Sci U S A. 1993;90:8925–8928.
   PubMed Web of Science ®Google Scholar
• Bazzoli C, Jullien V, le Tiec C, et al. Intracellular pharmacokinetics of antiretroviral drugs in HIV-infected patients, and their correlation with drug action. Clin Pharmacokinet. 2010;49:17–45.
   PubMed Web of Science ®Google Scholar
• Ehrhardt M, Mock M, Haefeli WE, et al. Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma, and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay. J Chromatogr B: Anal Technol Biomed Life Sci. 2007;850:249–258.
   PubMed Web of Science ®Google Scholar
• Becher F, Schlemmer D, Pruvost A, et al. Development of a direct assay for measuring intracellular AZT triphosphate in humans peripheral blood mononuclear cells. Anal Chem. 2002;74:4220–4227.
   PubMed Web of Science ®Google Scholar
• King T, Bushman L, Kiser J, et al. Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells. J Chromatogr B: Anal Technol Biomed Life Sci. 2006;843:147–156.
   PubMed Web of Science ®Google Scholar
• Becher F, Landman R, Mboup S, et al. Monitoring of didanosine and stavudine intracellular trisphosphorylated anabolite concentrations in HIV-infected patients. AIDS. 2004;18:181–187.
   PubMed Web of Science ®Google Scholar
• Lowes S, LeLacheur R, Shoup R, et al. Recommendations on incurred sample stability (ISS) by GCC. Bioanalysis. 2014;6:2385–2390.
   PubMed Web of Science ®Google Scholar
• Chan LL, Laverty DJ, Smith T, et al. Accurate measurement of peripheral blood mononuclear cell concentration using image cytometry to eliminate RBC-induced counting error. J Immunol Methods. 2013;388:25–32.
   PubMed Web of Science ®Google Scholar
• Salmon-Ceron D, Lassalle R, Pruvost A, et al. Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial. Clin Infect Dis. 2003;36:1295–1304.
   PubMed Web of Science ®Google Scholar
• Savoie N, Garofolo F, van Amsterdam P, et al. White paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance. Bioanalysis. 2010;2010(2):1945–1960.
   Google Scholar
• Chan L, Laverty D, Smith T, et al. Accurate measurement of peripheral blood mononuclear cell concentration using image cytometry to eliminate RBC-induced counting error. J Immunol. 2013;388:25–32.
   Google Scholar
• C N, S A. Guava easycyte 6HT validation report. Bioreclamation IVT; 2016 Mar.
   Google Scholar
• Cadena-Herrera D, Esparza-de Lara JE, Ramirez-Ibanez ND, et al. Validation of three viable-cell counting methods: manual, semi-automated, and automated. Biotechnol Rep (Amst). 2015;7:9–16.
   PubMedGoogle Scholar
• I.H. RJR. Techniques and methodological approaches in breast cancer research. New York, Heidelberg, Dordrecht, London: Springer; 2014.
   Google Scholar
• Hollowell JG, van Assendelft OW, Gunter EW, et al. Hematological and iron-related analytes – reference data for persons aged 1 year and over: United States, 1988–94. Vital Health Stat. 2005;11:1–156.
   Google Scholar
• Riggio O, Angeloni S, Parente A, et al. Accuracy of the automated cell counters for management of spontaneous bacterial peritonitis. World J Gastroenterol. 2008;14:5689–5694.
   PubMed Web of Science ®Google Scholar
• de Smet D, van Moer G, Martens GA, et al. Use of the cell-dyn sapphire hematology analyzer for automated counting of blood cells in body fluids. Am J Clin Pathol. 2010;133:291–299.
   PubMed Web of Science ®Google Scholar
• Cordell RL, Hill SJ, Ortori CA, et al. Quantitative profiling of nucleotides and related phosphate-containing metabolites in cultured mammalian cells by liquid chromatography tandem electrospray mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci. 2008;871:115–124.
   PubMed Web of Science ®Google Scholar
• Krediet CJ, DeNofrio JC, Caruso C, et al. Rapid, precise, and accurate counts of symbiodinium cells using the guava flow cytometer, and a comparison to other methods. PLoS ONE. 2015;10:1–19.
   Web of Science ®Google Scholar
• D’Avolio A, Simiele M, Siccardi M, et al. A HPLC–MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. J Pharm Biomed Anal. 2011;54:779–788.
   PubMed Web of Science ®Google Scholar
• Ibanez A, Puig T, Elias J, et al. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. AIDS. 1999;13:1045–1049.
   PubMed Web of Science ®Google Scholar
• Teare JM, Islam R, Flanagan R, et al. Measurement of nucleic acid concentrations using the DyNA quant and the GeneQuant. Biotechniques. 1997;22:1170–1174.
   PubMed Web of Science ®Google Scholar
• Manchester KL. Use of UV methods for measurement of protein and nucleic acid concentrations. Biotechniques. 1996;20:968–970.
   PubMed Web of Science ®Google Scholar
• Martin RM, Leonhardt H, Cardoso MC. DNA labeling in living cells. Cytometry A. 2005;67:45–52.
   PubMedGoogle Scholar
• Suzuki T, Fujikura K, Higashiyama T, et al. DNA staining for fluorescence and laser confocal microscopy. J Histochem Cytochem. 1997;45:49–53.
   PubMed Web of Science ®Google Scholar
• Doležel J, Bartoš J, Voglmayr H, et al. Letter to the editor. Cytometry Part A. 2003;51A:127–128.
   Google Scholar
• Russo J, Russo IH. Techniques and methodological approaches in breast cancer research. London: Springer New York Heidelberg Dordrecht; 2014.
   Google Scholar
• Serth J, Kuczyk MA, Paeslack U, et al. Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sections. Am J Pathol. 2000;156:1189–1196.
   PubMed Web of Science ®Google Scholar
• Morton NE. Parameters of the human genome. Proc Natl Acad Sci U S A. 1991;88:7474–7476.
   PubMed Web of Science ®Google Scholar
• Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487–491.
   PubMed Web of Science ®Google Scholar
• Lo YM, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64:218–224.
   PubMed Web of Science ®Google Scholar
• Anderson SB, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–465.
   PubMed Web of Science ®Google Scholar
• Qiu C, Sanchez SE, Hevner K, et al. Placental mitochondrial DNA content and placental abruption: a pilot study. BMC Res Notes. 2015;8:447.
   PubMedGoogle Scholar
• Gahan ME, Miller F, Lewin SR, et al. Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction. J Clin Virol. 2001;22:241–247.
   PubMed Web of Science ®Google Scholar
• Miura T, Goto M, Hosoya N, et al. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. J Med Virol. 2003;70:497–505.
   PubMed Web of Science ®Google Scholar
• Xiao D, Ling J, Tarnowski T. The determination of human PBMC counts using a genomic DNA standard with fluorescent quantitation, poster presentation. Washington, DC: AAPS PharmSci 360; 2018.
   Google Scholar
• Genome Reference Consortium Human Build 38 patch release 11 (GRCh38.p11), Human Genome Corsortium: https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.37. 2017: date last accessed 2018 Apr 2.
   Google Scholar
• Wu J, Cunanan J, Kulatunga T, et al. Stability of genomic DNA at various storage conditions poster#: QAC 03 May 12–15, 2009. International Society for Biological and Environmental Repositories (ISBER), 2009 Annual Meeting.
   Google Scholar